investorscraft@gmail.com

Intrinsic Value of ABIOMED, Inc. (ABMD)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-03-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %21.7NaN
Revenue, $1032NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m891NaN
Operating income, $m141NaN
EBITDA, $m169NaN
Interest expense (income), $mNaN
Earnings before tax, $m191NaN
Tax expense, $m54NaN
Net income, $m137NaN

BALANCE SHEET

Cash and short-term investments, $m759NaN
Total assets, $m1673NaN
Adjusted assets (=assets-cash), $m915NaN
Average production assets, $m318NaN
Working capital, $m838NaN
Total debt, $m10NaN
Total liabilities, $m170NaN
Total equity, $m1503NaN
Debt-to-equity ratio0.007NaN
Adjusted equity ratio0.817NaN

CASH FLOW

Net income, $m137NaN
Depreciation, amort., depletion, $m28NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m285NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-36NaN
Free cash flow, $m321NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m838
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount